{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05609370",
            "orgStudyIdInfo": {
                "id": "BGB-A317-LBL-007-201"
            },
            "secondaryIdInfos": [
                {
                    "id": "CTR20223077",
                    "type": "REGISTRY",
                    "domain": "ChinaDrugTrials"
                }
            ],
            "organization": {
                "fullName": "BeiGene",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer",
            "officialTitle": "A Phase 1b/2, Randomized, Open-Label Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine as Maintenance Therapy in Patients With Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "a-study-investigating-the-efficacy-and-safety-of-lbl-plus-tislelizumab-in-combination-with-bevacizumab-plus-fluoropyrimidine-versus-bevacizumab-plus-fluoropyrimidine-in-participants-with-unresectable-or-metastatic-colorectal-cancer"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-01-29",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-04",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2028-04",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-10-20",
            "studyFirstSubmitQcDate": "2022-11-01",
            "studyFirstPostDateStruct": {
                "date": "2022-11-08",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-16",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-17",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "BeiGene",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This is a Phase 1b/2 study to investigate the efficacy and safety of LBL-007 plus Tislelizumab when administered in combination with bevacizumab plus fluoropyrimidine to participants with colorectal cancer."
        },
        "conditionsModule": {
            "conditions": [
                "Unresectable or Metastatic Microsatellite Stable/Mismatch Repair Proficient Colorectal Cancer"
            ],
            "keywords": [
                "Colorectal Cancer",
                "Microsatellite Stable",
                "Mismatch Repair Proficient",
                "Maintenance Therapy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 226,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1b: Cohort-1: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                    "type": "EXPERIMENTAL",
                    "description": "LBL-007 + tislelizumab + bevacizumab + capecitabine",
                    "interventionNames": [
                        "Drug: LBL-007",
                        "Drug: Tislelizumab",
                        "Drug: Bevacizumab biosimilar",
                        "Drug: Capecitabine"
                    ]
                },
                {
                    "label": "Phase 1b: Cohort 1a: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                    "type": "EXPERIMENTAL",
                    "description": "LBL-007 + tislelizumab + bevacizumab + capecitabine",
                    "interventionNames": [
                        "Drug: LBL-007",
                        "Drug: Tislelizumab",
                        "Drug: Bevacizumab biosimilar",
                        "Drug: Capecitabine"
                    ]
                },
                {
                    "label": "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                    "type": "EXPERIMENTAL",
                    "description": "LBL-007 + tislelizumab (low dose every 3 weeks or high dose every 4 weeks) + bevacizumab (7.5 mg/kg once every 2 weeks or 5 mg/kg once every 3 weeks)+ fluoropyrimidine (5-FU or capecitabine)",
                    "interventionNames": [
                        "Drug: LBL-007",
                        "Drug: Tislelizumab",
                        "Drug: Bevacizumab biosimilar",
                        "Drug: Capecitabine",
                        "Drug: 5-Fluorouracil"
                    ]
                },
                {
                    "label": "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                    "type": "EXPERIMENTAL",
                    "description": "LBL-007 + tislelizumab (low dose every 3 weeks or high dose every 4 weeks) + bevacizumab (7.5 mg/kg once every 2 weeks or 5 mg/kg once every 3 weeks) + fluoropyrimidine (5-FU or capecitabine)",
                    "interventionNames": [
                        "Drug: LBL-007",
                        "Drug: Tislelizumab",
                        "Drug: Bevacizumab biosimilar",
                        "Drug: Capecitabine",
                        "Drug: 5-Fluorouracil"
                    ]
                },
                {
                    "label": "Phase 2: Arm B: LBL-007 + bevacizumab + fluoropyrimidine",
                    "type": "EXPERIMENTAL",
                    "description": "LBL-007 + bevacizumab (7.5 mg/kgonce every 2 weeks or 5 mg/kg once every 3 weeks) + fluoropyrimidine (5-FU or capecitabine)",
                    "interventionNames": [
                        "Drug: LBL-007",
                        "Drug: Bevacizumab biosimilar",
                        "Drug: Capecitabine",
                        "Drug: 5-Fluorouracil"
                    ]
                },
                {
                    "label": "Phase 2: Arm C and Arm E: bevacizumab + fluoropyrimidine",
                    "type": "OTHER",
                    "description": "bevacizumab (7.5 mg/kg once every 2 weeks or 5 mg/kg once every 3 weeks) + fluoropyrimidine (5-FU or capecitabine)",
                    "interventionNames": [
                        "Drug: Bevacizumab biosimilar",
                        "Drug: Capecitabine",
                        "Drug: 5-Fluorouracil"
                    ]
                },
                {
                    "label": "Phase 1b: Cohort 1b: LBL-007 + Tislelizumab + Bevacizumab + 5- Flurouracil (5-FU)",
                    "type": "EXPERIMENTAL",
                    "description": "LBL-007 + Tislelizumab + Bevacizumab + 5- Flurouracil",
                    "interventionNames": [
                        "Drug: LBL-007",
                        "Drug: Tislelizumab",
                        "Drug: Bevacizumab biosimilar",
                        "Drug: 5-Fluorouracil"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "LBL-007",
                    "description": "Low dose intravenously (IV) once every 3 weeks.",
                    "armGroupLabels": [
                        "Phase 1b: Cohort-1: LBL-007 + tislelizumab + bevacizumab + capecitabine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "LBL-007",
                    "description": "Medium dose IV once every 3 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 1a: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                        "Phase 1b: Cohort 1b: LBL-007 + Tislelizumab + Bevacizumab + 5- Flurouracil (5-FU)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "LBL-007",
                    "description": "High dose IV once every 2 or 3 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm B: LBL-007 + bevacizumab + fluoropyrimidine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tislelizumab",
                    "description": "Low dose IV once every 3 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 1a: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                        "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 1b: Cohort-1: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                        "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine"
                    ],
                    "otherNames": [
                        "BGB-A-317"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tislelizumab",
                    "description": "High dose IV once every 4 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 1b: LBL-007 + Tislelizumab + Bevacizumab + 5- Flurouracil (5-FU)",
                        "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine"
                    ],
                    "otherNames": [
                        "BGB-A-317"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bevacizumab biosimilar",
                    "description": "7.5 mg/kg IV every 3 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 1a: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                        "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 1b: Cohort-1: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                        "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm B: LBL-007 + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm C and Arm E: bevacizumab + fluoropyrimidine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Bevacizumab biosimilar",
                    "description": "5 mg/kg IV once every 2 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 1b: LBL-007 + Tislelizumab + Bevacizumab + 5- Flurouracil (5-FU)",
                        "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm B: LBL-007 + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm C and Arm E: bevacizumab + fluoropyrimidine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Capecitabine",
                    "description": "850 milligrams per square meter (mg/m\\^2) twice daily orally for 2 weeks, followed by a one-week treatment break every 3 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 1a: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                        "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 1b: Cohort-1: LBL-007 + tislelizumab + bevacizumab + capecitabine",
                        "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm B: LBL-007 + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm C and Arm E: bevacizumab + fluoropyrimidine"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "5-Fluorouracil",
                    "description": "1600 to 2400 mg/m\\^2 IV every 2 weeks",
                    "armGroupLabels": [
                        "Phase 1b: Cohort 1b: LBL-007 + Tislelizumab + Bevacizumab + 5- Flurouracil (5-FU)",
                        "Phase 1b: Cohort 2: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm A and Arm D: LBL-007 + tislelizumab + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm B: LBL-007 + bevacizumab + fluoropyrimidine",
                        "Phase 2: Arm C and Arm E: bevacizumab + fluoropyrimidine"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Phase 1b: Number of participants with Adverse events (AE) and Serious AEs (SAE)",
                    "description": "AEs and SAE are characterized by type, frequency, severity (as graded by National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0 \\[NCI-CTCAE v5.0\\])",
                    "timeFrame": "First Cycle of treatment (21 days)"
                },
                {
                    "measure": "Phase 2: Progression Free Survival (PFS) as Assessed by The Investigator in PD-L1 Positive Arms A and C",
                    "description": "PFS, as assessed by the investigator per RECIST v1.1 is defined as the time from the date of randomization to the date of first documentation of disease progression or death, whichever occurs first",
                    "timeFrame": "Approximately 44 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Phase 2: Overall Survival (OS) as Assessed by The Investigator in PD-L1 Positive Arms A and C and PD-L1 Negative Arms D and E",
                    "description": "OS is defined as the time from the date of randomization until the date of death from any cause.",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: PFS 2 as Assessed by The Investigator in PD-L1 Positive Arms A and C and PD-L1 Negative Arms D and E",
                    "description": "PFS2 is defined as the time from the date of randomization to the date of documentation of disease progression in second-line treatment, or death, whichever occurs first",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: Objective Response rate (ORR) as Assessed by The Investigator in PD-L1 Positive Arms A and C and PD-L1 Negative Arms D and E",
                    "description": "ORR is defined as the proportion of participants with a confirmed complete response (CR) or partial response (PR) from the time of randomization",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: Duration of response (DOR) as Assessed by The Investigator in PD-L1 Positive Arms A and C and PD-L1 Negative arms D and E",
                    "description": "DOR is defined as the time from the first confirmed objective response after randomization until the first documentation of disease progression or death, whichever comes first",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: Progression Free Survival (PFS) as Assessed by The Investigator in PD-L1 Negative Arms D and E",
                    "description": "PFS, as assessed by the investigator per RECIST v1.1 is defined as the time from the date of randomization to the date of first documentation of disease progression or death, whichever occurs first",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: Progression Free Survival (PFS) as Assessed by The Investigator in Arms A + D and Arms C + E Regardless of PD-L1 Expression",
                    "description": "PFS, as assessed by the investigator per RECIST v1.1 is defined as the time from the date of randomization to the date of first documentation of disease progression or death, whichever occurs first",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: Overall Survival (OS) as Assessed by The Investigator in Arms A + D and Arms C + E Regardless of PD-L1 Expression",
                    "description": "OS is defined as the time from the date of randomization until the date of death from any cause.",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: PFS 2 as Assessed by The Investigator in Arms A + D and Arms C + E Regardless of PD-L1 Expression",
                    "description": "PFS, as assessed by the investigator per RECIST v1.1 is defined as the time from the date of randomization to the date of first documentation of disease progression or death, whichever occurs first",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: Objective Response rate (ORR) as Assessed by The Investigator in Arms A + D and Arms C + E Regardless of PD-L1 Expression",
                    "description": "ORR is defined as the proportion of participants with a confirmed complete response (CR) or partial response (PR) from the time of randomization",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2: DOR as Assessed by The Investigator in Arms A + D and Arms C + E Regardless of PD-L1 Expression",
                    "description": "DOR is defined as the time from the first confirmed objective response after randomization until the first documentation of disease progression or death, whichever comes first",
                    "timeFrame": "Approximately 44 months"
                },
                {
                    "measure": "Phase 2 : Number of participants with Adverse events (AE) and Serious AEs (SAE)",
                    "description": "AEs and SAE are characterized by type, frequency, severity as graded by NCI-CTCAE v5.0",
                    "timeFrame": "Up to last dose + 30 days (Approximately 44 months)"
                },
                {
                    "measure": "Phase 1b: Maximum Concentration (Cmax) of LBL-007",
                    "timeFrame": "Cycle 1 Day 1 (C1D1) Predose, End of Infusion (EOI) 6 hours (h), C1D2, C1D4, C1D8, and C1D15, C2 to C25 D1 Predose and EOI (each cycle 21 days)"
                },
                {
                    "measure": "Phase 1b: Time to achieve Maximum Concentration (Tmax) of LBL-007",
                    "timeFrame": "Cycle 1 Day 1 (C1D1) Predose, End of Infusion (EOI) 6 hours (h), C1D2, C1D4, C1D8, and C1D15, C2 to C25 D1 Predose and EOI (each cycle 21 days)"
                },
                {
                    "measure": "Phase 1b: Area Under the Concentration Curve from Day 0 to Day 21(AUC 0-21)",
                    "timeFrame": "Cycle 1 Day 1 (C1D1) Predose, End of Infusion (EOI) 6 hours (h), C1D2, C1D4, C1D8, and C1D15, C2 to C25 D1 Predose and EOI (each cycle 21 days)"
                },
                {
                    "measure": "Phase 1b: Mean Half Life (t1/2) of LBL-007",
                    "timeFrame": "Cycle 1 Day 1 (C1D1) Predose, End of Infusion (EOI) 6 hours (h), C1D2, C1D4, C1D8, and C1D15, C2 to C25 D1 Predose and EOI (each cycle 21 days)"
                },
                {
                    "measure": "Phase 1b: Clearance (CL) of LBL-007",
                    "timeFrame": "Cycle 1 Day 1 (C1D1) Predose, End of Infusion (EOI) 6 hours (h), C1D2, C1D4, C1D8, and C1D15, C2 to C25 D1 Predose and EOI (each cycle 21 days)"
                },
                {
                    "measure": "Phase 1b: Apparent Volume of Distribution (Vz) of LBL-007",
                    "timeFrame": "Cycle 1 Day 1 (C1D1) Predose, End of Infusion (EOI) 6 hours (h), C1D2, C1D4, C1D8, and C1D15, C2 to C25 D1 Predose and EOI (each cycle 21 days)"
                },
                {
                    "measure": "Phase 2: Cmax of LBL-007, Tislelizumab, and Bevacizumab",
                    "timeFrame": "Up to approximately 27 months (predose at cycle 1,2,5,9,17, safety follow-up (each cycle 21 days))"
                },
                {
                    "measure": "Phase 2: Cmin of LBL-007, Tislelizumab, and Bevacizumab",
                    "timeFrame": "Cycle 1 Day 1 (C1D1) Predose, End of Infusion (EOI) 6 hours (h), C1D2, C1D4, C1D8, and C1D15, C2 to C25 D1 Predose and EOI (each cycle 21 days)"
                },
                {
                    "measure": "Number of Participants with anti-drug antibodies (ADAs) to Tislelizumab, and Bevacizumab in Arm A, Arm B and Arm D",
                    "timeFrame": "Up to approximately 27 months (predose at cycle 1,2,5,9,17, safety follow-up, and EOI at cycle 1 and 5 (each cycle 21 days))"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant must have measurable disease as defined per RECIST version 1.1\n* Has a histologically confirmed colorectal adenocarcinoma with metastatic or unresectable disease (Stage IV as defined by American Joint Committee on Cancer \\[AJCC\\] 8th edition)\n* No prior systemic therapy for colorectal cancer (CRC) in the metastatic setting except for the induction treatment of first-line therapy. Note: Local regional treatment performed during induction systemic treatment is allowed\n* Participants who have completed the first-line induction treatment, with an overall response of stable disease or better\n\nExclusion Criteria:\n\n* Participants whose disease has become resectable at the investigator's discretion during or after induction treatment are not eligible\n* Induction treatment initiated less than 6 months from completion of any prior neoadjuvant or adjuvant chemotherapy or radiotherapy which occurred later\n* Participants who have been treated with anti-epidermal growth factor receptor (EGFR) antibody in the induction treatment\n* Any prior therapy targeting T-cell stimulation or checkpoint pathways\n* Participants with B-raf proto-oncogene, serine/threonine kinase (BRAF)V600E mutations\n* Have locally or centrally confirmed microsatellite instability-high (MSI-H) by polymerase chain reaction (PCR) method or dMMR by immunohistochemistry (IHC) method\n\nNote: Other protocol defined criteria may apply.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "BeiGene",
                    "role": "CONTACT",
                    "phone": "1-877-828-5568",
                    "email": "clinicaltrials@beigene.com"
                }
            ],
            "locations": [
                {
                    "facility": "Alaska Oncologyand Hematology, Llc",
                    "status": "RECRUITING",
                    "city": "Anchorage",
                    "state": "Alaska",
                    "zip": "99508",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 61.21806,
                        "lon": -149.90028
                    }
                },
                {
                    "facility": "Banner Md Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Gilbert",
                    "state": "Arizona",
                    "zip": "85234",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.35283,
                        "lon": -111.78903
                    }
                },
                {
                    "facility": "Toi Clinical Research",
                    "status": "RECRUITING",
                    "city": "Cerritos",
                    "state": "California",
                    "zip": "90703",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.85835,
                        "lon": -118.06479
                    }
                },
                {
                    "facility": "Usc Norris Comprehensive Cancer Center (Nccc)",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90033",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "Baptist Md Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Jacksonville",
                    "state": "Florida",
                    "zip": "32207",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.33218,
                        "lon": -81.65565
                    }
                },
                {
                    "facility": "Fort Wayne Medical Oncology and Hematology",
                    "status": "RECRUITING",
                    "city": "Fort Wayne",
                    "state": "Indiana",
                    "zip": "46804",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.1306,
                        "lon": -85.12886
                    }
                },
                {
                    "facility": "University of Kentucky Markey Cancer Center",
                    "status": "RECRUITING",
                    "city": "Lexington",
                    "state": "Kentucky",
                    "zip": "40536",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 37.98869,
                        "lon": -84.47772
                    }
                },
                {
                    "facility": "Pontchartrain Cancer Center",
                    "status": "RECRUITING",
                    "city": "Covington",
                    "state": "Louisiana",
                    "zip": "70433",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 30.47549,
                        "lon": -90.10042
                    }
                },
                {
                    "facility": "Ochsner Clinic Foundation",
                    "status": "RECRUITING",
                    "city": "New Orleans",
                    "state": "Louisiana",
                    "zip": "70121",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.95465,
                        "lon": -90.07507
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "St Vincent Frontier Cancer Center",
                    "status": "RECRUITING",
                    "city": "Billings",
                    "state": "Montana",
                    "zip": "59102",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 45.78329,
                        "lon": -108.50069
                    }
                },
                {
                    "facility": "University of New Mexico Cancer Center",
                    "status": "RECRUITING",
                    "city": "Albuquerque",
                    "state": "New Mexico",
                    "zip": "87102",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.08449,
                        "lon": -106.65114
                    }
                },
                {
                    "facility": "Perlmutter Cancer Center At Winthrop Oncology Hematology Associatesnyu Winthrop Hospital",
                    "status": "RECRUITING",
                    "city": "Mineola",
                    "state": "New York",
                    "zip": "11501",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.74927,
                        "lon": -73.64068
                    }
                },
                {
                    "facility": "Laura and Isaac Perlmutter Cancer Center At Nyu Langone Health",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10016",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Duke Cancer Center",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "Ut Health San Antonio Mays Cancer Center",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Virginia Cancer Specialists",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Cancer Care Northwest",
                    "status": "RECRUITING",
                    "city": "Spokane Valley",
                    "state": "Washington",
                    "zip": "99216",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 47.67323,
                        "lon": -117.23937
                    }
                },
                {
                    "facility": "Blacktown Cancer and Haematology Centre",
                    "status": "RECRUITING",
                    "city": "Blacktown",
                    "state": "New South Wales",
                    "zip": "2148",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.76667,
                        "lon": 150.91667
                    }
                },
                {
                    "facility": "Border Medical Oncology",
                    "status": "RECRUITING",
                    "city": "East Albury",
                    "state": "New South Wales",
                    "zip": "2640",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -36.08144,
                        "lon": 146.92991
                    }
                },
                {
                    "facility": "Orange Health Service (Central West Cancer Care Centre)",
                    "status": "RECRUITING",
                    "city": "Orange",
                    "state": "New South Wales",
                    "zip": "2800",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.28397,
                        "lon": 149.10018
                    }
                },
                {
                    "facility": "Riverina Cancer Care Centre",
                    "status": "RECRUITING",
                    "city": "Wagga Wagga",
                    "state": "New South Wales",
                    "zip": "2650",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -35.12577,
                        "lon": 147.35375
                    }
                },
                {
                    "facility": "Calvary Mater Newcastle",
                    "status": "RECRUITING",
                    "city": "Waratah",
                    "state": "New South Wales",
                    "zip": "2298",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -32.90667,
                        "lon": 151.72647
                    }
                },
                {
                    "facility": "Pindara Private Hospital",
                    "status": "RECRUITING",
                    "city": "Benowa",
                    "state": "Queensland",
                    "zip": "4217",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -28.01667,
                        "lon": 153.4
                    }
                },
                {
                    "facility": "Icon Cancer Care South Brisbane",
                    "status": "RECRUITING",
                    "city": "South Brisbane",
                    "state": "Queensland",
                    "zip": "4101",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -27.48034,
                        "lon": 153.02049
                    }
                },
                {
                    "facility": "Flinders Centre For Innovation in Cancer (Fcic)",
                    "status": "RECRUITING",
                    "city": "Bedford Park",
                    "state": "South Australia",
                    "zip": "5042",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -35.03333,
                        "lon": 138.56667
                    }
                },
                {
                    "facility": "Lyell McEwin Hospital",
                    "status": "RECRUITING",
                    "city": "Elizabeth Vale",
                    "state": "South Australia",
                    "zip": "5112",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -34.74857,
                        "lon": 138.66819
                    }
                },
                {
                    "facility": "Monash Health",
                    "status": "RECRUITING",
                    "city": "Clayton",
                    "state": "Victoria",
                    "zip": "3168",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.91667,
                        "lon": 145.11667
                    }
                },
                {
                    "facility": "Austin Health",
                    "status": "RECRUITING",
                    "city": "Heidelberg",
                    "state": "Victoria",
                    "zip": "3084",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.75,
                        "lon": 145.06667
                    }
                },
                {
                    "facility": "The Alfred Hospital",
                    "status": "RECRUITING",
                    "city": "Melbourne",
                    "state": "Victoria",
                    "zip": "3004",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -37.814,
                        "lon": 144.96332
                    }
                },
                {
                    "facility": "St John of God, Murdoch",
                    "status": "RECRUITING",
                    "city": "Murdoch",
                    "state": "Western Australia",
                    "zip": "6150",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -32.06987,
                        "lon": 115.83757
                    }
                },
                {
                    "facility": "One Clinical Research",
                    "status": "RECRUITING",
                    "city": "Nedlands",
                    "state": "Western Australia",
                    "zip": "6009",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -31.98184,
                        "lon": 115.8073
                    }
                },
                {
                    "facility": "The Second Hospital of Anhui Medical University",
                    "status": "RECRUITING",
                    "city": "Hefei",
                    "state": "Anhui",
                    "zip": "230601",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.86389,
                        "lon": 117.28083
                    }
                },
                {
                    "facility": "Peking University First Hospital",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "state": "Beijing",
                    "zip": "100034",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Beijing Tsinghua Changgung Hospital",
                    "status": "RECRUITING",
                    "city": "Beijing",
                    "state": "Beijing",
                    "zip": "102218",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.9075,
                        "lon": 116.39723
                    }
                },
                {
                    "facility": "Fujian Medical University Union Hospital",
                    "status": "RECRUITING",
                    "city": "Fuzhou",
                    "state": "Fujian",
                    "zip": "350001",
                    "country": "China",
                    "geoPoint": {
                        "lat": 26.06139,
                        "lon": 119.30611
                    }
                },
                {
                    "facility": "Quanzhou First Affliated Hospital of Fujian Medical University",
                    "status": "RECRUITING",
                    "city": "Quanzhou",
                    "state": "Fujian",
                    "zip": "362000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 24.91389,
                        "lon": 118.58583
                    }
                },
                {
                    "facility": "The First Affiliated Hospital of Xiamen University",
                    "status": "RECRUITING",
                    "city": "Xiamen",
                    "state": "Fujian",
                    "zip": "361003",
                    "country": "China",
                    "geoPoint": {
                        "lat": 24.47979,
                        "lon": 118.08187
                    }
                },
                {
                    "facility": "Gansu Provincial Hospital",
                    "status": "RECRUITING",
                    "city": "Lanzhou",
                    "state": "Gansu",
                    "zip": "730000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 36.05701,
                        "lon": 103.83987
                    }
                },
                {
                    "facility": "Zhujiang Hospital of Southern Medical University",
                    "status": "RECRUITING",
                    "city": "Guangzhou",
                    "state": "Guangdong",
                    "zip": "510000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.11667,
                        "lon": 113.25
                    }
                },
                {
                    "facility": "The First Affiliated Hospital of Shantou University Medical College",
                    "status": "RECRUITING",
                    "city": "Shantou",
                    "state": "Guangdong",
                    "zip": "515041",
                    "country": "China",
                    "geoPoint": {
                        "lat": 23.36814,
                        "lon": 116.71479
                    }
                },
                {
                    "facility": "Nanyang Central Hospital",
                    "status": "RECRUITING",
                    "city": "Nanyang",
                    "state": "Henan",
                    "zip": "473000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 32.99472,
                        "lon": 112.53278
                    }
                },
                {
                    "facility": "Henan Cancer Hospital",
                    "status": "RECRUITING",
                    "city": "Zhengzhou",
                    "state": "Henan",
                    "zip": "450000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 34.75778,
                        "lon": 113.64861
                    }
                },
                {
                    "facility": "Hubei Cancer Hospital",
                    "status": "RECRUITING",
                    "city": "Wuhan",
                    "state": "Hubei",
                    "zip": "430079",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.58333,
                        "lon": 114.26667
                    }
                },
                {
                    "facility": "Hunan Cancer Hospital",
                    "status": "RECRUITING",
                    "city": "Changsha",
                    "state": "Hunan",
                    "zip": "410013",
                    "country": "China",
                    "geoPoint": {
                        "lat": 28.19874,
                        "lon": 112.97087
                    }
                },
                {
                    "facility": "The First Peoples Hospital of Changzhou",
                    "status": "RECRUITING",
                    "city": "Changzhou",
                    "state": "Jiangsu",
                    "zip": "213000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.77359,
                        "lon": 119.95401
                    }
                },
                {
                    "facility": "Affiliated Hospital of Jiangnan University South Campus",
                    "status": "RECRUITING",
                    "city": "Wuxi",
                    "state": "Jiangsu",
                    "zip": "214122",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.56887,
                        "lon": 120.28857
                    }
                },
                {
                    "facility": "The First Hospital of Jilin University",
                    "status": "RECRUITING",
                    "city": "Changchun",
                    "state": "Jilin",
                    "zip": "130021",
                    "country": "China",
                    "geoPoint": {
                        "lat": 43.88,
                        "lon": 125.32278
                    }
                },
                {
                    "facility": "General Hospital of Ningxia Medical University",
                    "status": "RECRUITING",
                    "city": "Yinchuan",
                    "state": "Ningxia",
                    "zip": "750004",
                    "country": "China",
                    "geoPoint": {
                        "lat": 38.46806,
                        "lon": 106.27306
                    }
                },
                {
                    "facility": "Shandong Cancer Hospital",
                    "status": "RECRUITING",
                    "city": "Jinan",
                    "state": "Shandong",
                    "zip": "250117",
                    "country": "China",
                    "geoPoint": {
                        "lat": 36.66833,
                        "lon": 116.99722
                    }
                },
                {
                    "facility": "Jining No Peoples Hospital",
                    "status": "RECRUITING",
                    "city": "Jining",
                    "state": "Shandong",
                    "zip": "272000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 35.405,
                        "lon": 116.58139
                    }
                },
                {
                    "facility": "Linyi Peoples Hospital",
                    "status": "RECRUITING",
                    "city": "Linyi",
                    "state": "Shandong",
                    "zip": "276000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 35.06306,
                        "lon": 118.34278
                    }
                },
                {
                    "facility": "Qingdao Municipal Hospital",
                    "status": "RECRUITING",
                    "city": "Qingdao",
                    "state": "Shandong",
                    "zip": "266000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 36.06488,
                        "lon": 120.38042
                    }
                },
                {
                    "facility": "Renji Hospital Shanghai Jiao Tong University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "zip": "200000",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Shanghai Th Peoples Hospital",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "zip": "200072",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Shanghai East Hospital Branch Hospital",
                    "status": "RECRUITING",
                    "city": "Shanghai",
                    "state": "Shanghai",
                    "zip": "200123",
                    "country": "China",
                    "geoPoint": {
                        "lat": 31.22222,
                        "lon": 121.45806
                    }
                },
                {
                    "facility": "Tianjin Medical University Cancer Institute and Hospital",
                    "status": "RECRUITING",
                    "city": "Tianjin",
                    "state": "Tianjin",
                    "zip": "300060",
                    "country": "China",
                    "geoPoint": {
                        "lat": 39.14222,
                        "lon": 117.17667
                    }
                },
                {
                    "facility": "Karamay Central Hospital of Xinjiang",
                    "status": "RECRUITING",
                    "city": "Karamay",
                    "state": "Xinjiang",
                    "zip": "834009",
                    "country": "China",
                    "geoPoint": {
                        "lat": 45.58473,
                        "lon": 84.88724
                    }
                },
                {
                    "facility": "The Xinjiang Uygur Autonomous Region Peoples Hospital",
                    "status": "RECRUITING",
                    "city": "Urumqi",
                    "state": "Xinjiang",
                    "zip": "830001",
                    "country": "China",
                    "geoPoint": {
                        "lat": 43.80096,
                        "lon": 87.60046
                    }
                },
                {
                    "facility": "Zhejiang University College of Medicine Second Affiliated Hospital",
                    "status": "RECRUITING",
                    "city": "Hangzhou",
                    "state": "Zhejiang",
                    "zip": "310009",
                    "country": "China",
                    "geoPoint": {
                        "lat": 30.29365,
                        "lon": 120.16142
                    }
                },
                {
                    "facility": "Pan American Oncology Trials, Llc",
                    "status": "RECRUITING",
                    "city": "Rio Piedras",
                    "zip": "00935",
                    "country": "Puerto Rico",
                    "geoPoint": {
                        "lat": 18.39745,
                        "lon": -66.04989
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000015179",
                    "term": "Colorectal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000012002",
                    "term": "Rectal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17890",
                    "name": "Colorectal Neoplasms",
                    "asFound": "Colorectal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14844",
                    "name": "Rectal Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068258",
                    "term": "Bevacizumab"
                },
                {
                    "id": "C000707970",
                    "term": "Tislelizumab"
                },
                {
                    "id": "D000069287",
                    "term": "Capecitabine"
                },
                {
                    "id": "D000005472",
                    "term": "Fluorouracil"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000020533",
                    "term": "Angiogenesis Inhibitors"
                },
                {
                    "id": "D000043924",
                    "term": "Angiogenesis Modulating Agents"
                },
                {
                    "id": "D000006133",
                    "term": "Growth Substances"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000006131",
                    "term": "Growth Inhibitors"
                },
                {
                    "id": "D000000964",
                    "term": "Antimetabolites, Antineoplastic"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M377",
                    "name": "Capecitabine",
                    "asFound": "200",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8600",
                    "name": "Fluorouracil",
                    "asFound": "According",
                    "relevance": "HIGH"
                },
                {
                    "id": "M137899",
                    "name": "Tislelizumab",
                    "asFound": "Nerve block",
                    "relevance": "HIGH"
                },
                {
                    "id": "M246",
                    "name": "Bevacizumab",
                    "asFound": "Non-",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M22318",
                    "name": "Angiogenesis Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M9231",
                    "name": "Growth Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}